A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
Public ClinicalTrials.gov record NCT03379311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-Label, Multiple Dose, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
Study identification
- NCT ID
- NCT03379311
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Allakos Inc.
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- AK002 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2018
- Primary completion
- Aug 7, 2019
- Completion
- Aug 7, 2019
- Last update posted
- Aug 28, 2019
2018 – 2019
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Byers Eye Institute at Stanford University | Palo Alto | California | 94303 | — |
| Riverside Clinical Research | Edgewater | Florida | 32132 | — |
| University of Maryland, Department of Ophthalmology and Visual Sciences | Baltimore | Maryland | 21201 | — |
| Ocular Immunology and Uveitis Foundation | Waltham | Massachusetts | 02451 | — |
| Tauber Eye Center | Kansas City | Missouri | 64111 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Metropolitan Eye Research and Surgery Institute | Palisades Park | New Jersey | 07650 | — |
| UPMC Eye Center | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03379311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03379311 live on ClinicalTrials.gov.